Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2014.460 | A Retrospective Study to Assess the Role of Prophylactic Anti-viral Therapies for Patients with CD20+ Lymphoma Receiving Anti-B cell Therapies | Prof. YEO Winnie |
2016.156 | RETROSPECTIVE REVIEW OF TUMOUR CHARACTERISTICS AND OUTCOMES OF BREAST CANCER PATIENTS |
Prof. YEO Winnie 楊明明 |
2016.290 | A Phase III open-label, multicenter trial of avelumab (MSB0010718C) as a third-line treatment of unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma |
Prof. YEO Winnie 楊明明 |
2017.320 | A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab in Combination with Oxaliplatin plus Fluoropyrimidine versus Oxaliplatin plus Fluoropyrimidine in Subjects with Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer |
Prof. YEO Winnie 楊明明 |
2016.435 | A prospective study of circulating and urinary isoflavones and lignans concentration at 60-m after diagnosis and the risk of recurrence and mortality in Chinese women with early-stage breast cancer | Prof. YEO Winnie |
2014.529 | A randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy | Prof. YEO Winnie |
2017.356 | China local BRCA testing and exploration of ovarian cancer treatment outcomes of different BRCA status in newly diagnosed epithelial ovarian cancer patients |
Prof. YEO Winnie 楊明明 |
2016.013 | A Randomized Study to Determine the Efficacy and Tolerability of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese breast cancer patients. |
Prof. YEO Winnie 楊明明 |
2015.696 | RETROSPECTIVE REVIEW OF EFFICACY AND TOLERABILITY OF T-DM1 IN ADVANCED HER2+ BREAST CANCER |
Prof. YEO Winnie 楊明明 |
2014.584 | A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer | Prof. YEO Winnie |
2015.689 | A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma |
Prof. YEO Winnie 楊明明 |
2015.507 | A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician’s Choice for Metastatic Triple Negative Breast Cancer (mTNBC) – (KEYNOTE-119) |
Prof. YEO Winnie 楊明明 |
2014.078 | The prognostic significance of combination of AFP, DCP and AFP L3 as biomarkers in hepatocellular carcinoma | Prof. YEO Winnie |
2016.010 | Cancer Health Literacy among Chinese cancer patients in Hong Kong | Prof. YEO Winnie |
2024.409 | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy | Prof. YEO Winnie |
2025.159 | Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT) | Prof. YEO Winnie |
2024.342 | A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator’s Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 (CLARITY-Gastric 01) | Prof. YEO Winnie |
2025.373 | A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer | Prof. YEO Winnie |
2024.096 | An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer | Prof. YEO Winnie |
2024.137 | A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician’s Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma) | Prof. YEO Winnie |
2025.307 | ASKHER2-China: Perceptions, attitudes, and behaviors towards the risk of disease recurrence among women with early-stage HER2+ breast cancer in mainland China and Hong Kong | Prof. YEO Winnie |
2023.240 | Surgical accuracy and clinical outcomes of image-free versus image-based robotic-assisted total knee arthroplasty | Dr. YEE King Hang |
2020.505 | Sterilized 3D PRINTed bone models versus conventional CT imaging for operative visualization for complex fracture repair surgery – A randomized multicentre study |
Dr. YEE King Hang 余敬行醫生 |
2020.659 | Determinants of osteoarthritis outcomes and progression in persons with late-stage knee osteoarthritis over 18 months | Dr. YEE Dennis King Hang |
2023.215 | Evaluation of the Effectiveness of Irreversible Electroporation for the Treatment of Prostate Cancer |
Dr. YEE Chi Hang 余知行 |
2020.019 | Robotic Radical Perineal Prostatectomy for Localized Prostate Cancer: A Feasibility Study |
Dr. YEE Chi Hang 余知行 |
2019.043 | Image-guided robot-assisted waterjet ablation of the prostate for patients with retention of urine due to benign prostatic obstruction |
Dr. YEE Chi Hang 余知行 |
2018.556 | Evaluation of the Effectiveness of High-intensity Focused Ultrasound for the Treatment of Prostate Cancer |
Dr. YEE Chi Hang 余知行 |
2020.018 | Evaluation of the Effectiveness of Cryotherapy for the Treatment of Prostate Cancer |
Dr. YEE Chi Hang 余知行 |
2019.535 | Music as an Adjunct for Pain and Anxiety Relief during Urological Procedure: A Randomized Control Trial |
Dr. YEE Chi Hang 余知行 |
2016.248 | Prevention of Lymphocele with Floseal in Renal Transplantation: A Multicentre Randomized Controlled Trial |
Dr. YEE Chi Hang 余知行 |
2015.613 | The Associations between Severity Level of Lower Urinary Tract Symptoms and Cardiovascular Risk in Male Patients in Hong Kong |
Dr. YEE Chi Hang 余知行 |
2016.588 | A Telephone Survey of Lower Urinary Tract Symptoms and Health in Hong Kong |
Dr. YEE Chi Hang 余知行 |
2017.394 | A Comprehensive Evaluation of the Transgender Population in Hong Kong: An Age-Matched, and Sex- or Preferred Gender-Matched Comparative Observational Study. |
Dr. YEE Chi Hang 余知行 |
2024.091 | Using social norms to promote physical activity among physically inactive college students in China: A randomized controlled trial |
Mr. YE Xinchen 叶欣晨 |
2025.002 | The Effectiveness of National Early Warning Score (NEWS) 2 in predicting Sudden Cardiac Arrest among Accident and Emergency Department Patients | Mr. YAU Yiu For |
2024.426 | The association of refractive error and deviation control of patients with intermittent exotropia in Hong Kong | Mr. YAU Tsz Him |
2014.255 | A cross-sectional study of cardio-metabolic risk in Chinese women with Polycystic Ovary Syndrome | Dr Yau Tse Ling |
2013.462 | A study of operational model efficiency: the improvement on service equality and efficiency in the delivery process of home based rehabilitation service (HBRS), by developing a new route planning system and a new discharge logistic plan, for the poor and | Mr. Yau Ngok |
2024.009 | Phenotypic landscape and genotype correlations in patients with SCN1A mutation | Dr YAU Lo Yee |
2022.105 | Neuro-modulation in patients with refractory epilepsy – a multicenter study in Hong Kong SAR, China |
Dr. YAU Lo Yee 邱露儀 |
2014.072 | Retrospective study of Use of Levetiracetam in Neonates | Dr. Yau Lo Yee |
2019.501 | Patients’ barriers to use Non-vitamin K novel oral anticoagulants in high risk nonvalvular atrial fibrillation patients in General Outpatient Clinic in Hong Kong |
Dr. YAU King Sun 游景新 |
2024.166 | The Effectiveness of Horticultural Therapy in Improving the Quality of Life of Patients and the Sense of Satisfaction of Caregivers in Specialized Palliative Care Unit | Ms. YAU Karen Ka Shuen |
2020.085 | Prognosis of severe dysphagia patient with dementia in local hospital |
Dr. YAU Ho Tuen 邱賀端 |
2019.442 | Twelve-Year Review on The Screening of Glycosuria in Obese School Children and Adolescents for Early Diagnosis of Type 2 Diabetes Mellitus, A Retrospective Study in Hong Kong | Dr YAU Ho Chung |
2016.266 | Hong Kong Childhood Diabetes Registry |
Dr. YAU Ho Chung 游可聰 |
2020.664 | Symptomatic vitamin D deficiency in children and adolescents: multi-centre experience in Hong Kong | Dr. YAU Ho Chung |
2023.031 | Diagnostic performance of a point-of-care high-sensitivity cardiac troponin I assay performed using the capillary blood samples of Chinese patients presenting with chest pain | Ms. YAU Hau Yee |
2010.340 | Vaccination uptake among elderly with chronic medical conditions in Hong Kong | Ms Yau Hau Yee |
Page 15 of 267.